↓ Skip to main content

Dove Medical Press

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women

Overview of attention for article published in Breast cancer targets and therapy, October 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#25 of 324)
  • High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
wikipedia
2 Wikipedia pages

Readers on

mendeley
25 Mendeley
Title
Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
Published in
Breast cancer targets and therapy, October 2011
DOI 10.2147/bctt.s11288
Pubmed ID
Authors

Victor G Vogel

Timeline
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 20%
Student > Master 4 16%
Student > Ph. D. Student 3 12%
Student > Bachelor 1 4%
Unspecified 1 4%
Other 2 8%
Unknown 9 36%
Readers by discipline Count As %
Medicine and Dentistry 4 16%
Biochemistry, Genetics and Molecular Biology 3 12%
Psychology 2 8%
Linguistics 1 4%
Agricultural and Biological Sciences 1 4%
Other 5 20%
Unknown 9 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2021.
All research outputs
#2,319,495
of 25,374,917 outputs
Outputs from Breast cancer targets and therapy
#25
of 324 outputs
Outputs of similar age
#11,530
of 143,955 outputs
Outputs of similar age from Breast cancer targets and therapy
#1
of 2 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 324 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,955 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them